Analysis of Immunotherapy in Triple negative breast cancer
Loading...
Identifiers
Publication date
Reading date
Collaborators
Advisors
Tutors
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Aseica
Share
Center
Department/Institute
Abstract
TNBC cancer is complicated, most is about PD-L1 mechanism. Too many kinds of immunotherapy have been developed to treat TNCB. Nowadays, is complicated a fast and 100% accurate treatment for TNBC, because of cancer complications like metastasis. Nevertheless, metastasis is still being researched to prevent it and assure a better immunotherapy. Also, the immunotherapies must be improved too.
Description
Bibliographic citation
Endorsement
Review
Supplemented By
Referenced by
Creative Commons license
Except where otherwised noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 Internacional